BY: Robert B. Sickels | IN: Personal Injury
The manufacturer of the popular blood pressure medication Valsartan has recalled the drug after cancer-causing substances were found in several lots. Mylan N.V. announced its voluntary U.S. recall in November, one day after the European Union effectively banned sales of Valsartan for the same reason, finding that some batches contained trace amounts of N-nitrosodiethylamine, a substance classified as a probable human carcinogen according to the International Agency for Research on Cancer.
As the U.S. Food & Drug Administration (FDA) outlined in a November 20 statement, the nationwide recall applies to at least 15 lots of products containing Valsartandistributed in the U.S. between March 2017 and November 2018.
Valsartan is used to treat high blood pressure and heart failure, and to reduce cardiovascular mortality following myocardial infarction. It’s also used in amlodipine or hydrochlorothiazide to treat high blood pressure.
If you take Valsartan or medications containing Valsartan, the FDA advises you to:
At Sommers Schwartz, we have seen the tragic consequences after dangerous drugs are released in the marketplace with inadequate testing, deceptive marketing, or other negligent conduct that puts patients’ health and lives at risk. Our experienced defective device and dangerous drug attorneys have a lengthy successful track record of holding pharmaceutical companies to account for the damage they cause and getting our clients the compensation that can help them recover and move forward.
If you believe you have been harmed by a recalled drug or medical device, please contact Sommers Schwartz to learn more about who we are, what we do, and how we can help you.
View all posts byRobert B. Sickels
For more than 30 years, Robert Sickels has successfully represented plaintiffs involved in complex personal injury, medical negligence, and products liability matters.